Showing results (81-90 of 89) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 89 results.
Ophthalmology|December 12, 2013
RADIANCE: a randomized controlled study of ranibizumab in patients with choroidal neovascularization secondary to pathologic myopiaSebastian Wolf, Vilma Jurate Balciuniene, Guna Laganovska, et al.
Thrombosis and Haemostasis|June 24, 2004
Impaired fibrinolysis in retinal vein occlusion: a role for genetic determinants of PAI-1 levelsAnna Maria Gori, Rossella Marcucci, Cinzia Fatini, et al.
Retina (Philadelphia, Pa.)|October 20, 2004
Outcome of choroidal neovascularization in angioid streaks after photodynamic therapyUgo Menchini, Gianni Virgili, Ugo Introini, et al.
Investigative Ophthalmology & Visual Science|June 5, 2012
Correlation between photoreceptor layer integrity and visual function in patients with Stargardt disease: implications for gene therapyFrancesco Testa, Settimio Rossi, Andrea Sodi, et al.
BMC Ophthalmology|January 24, 2016
Dietary profile of patients with Stargardt's disease and Retinitis Pigmentosa: is there a role for a nutritional approach?Francesco Sofi, Andrea Sodi, Fabrizio Franco, et al.
American Journal of Ophthalmology|September 12, 2003
Effect of lesion size, visual acuity, and lesion composition on visual acuity change with and without verteporfin therapy for choroidal neovascularization secondary to age-related macular degeneration: TAP and VIP report no. 1Keven J Blinder, Shannon Bradley, Neil M Bressler, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|April 13, 2005
Verteporfin therapy of subfoveal minimally classic choroidal neovascularization in age-related macular degeneration: 2-year results of a randomized clinical trialMohammad Azab, David S Boyer, Neil M Bressler, et al.
Retina (Philadelphia, Pa.)|April 13, 2004
Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: meta-analysis of 2-year safety results in three randomized clinical trials: Treatment Of Age-Related Macular Degeneration With Photodynamic Therapy and Verteporfin In Photodynamic Therapy Study Report no. 4Mohammad Azab, Mustapha Benchaboune, Kevin J Blinder, et al.
Ophthalmology|April 12, 2003
Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia: 2-year results of a randomized clinical trial--VIP report no. 3Kevin J Blinder, Mark S Blumenkranz, Neil M Bressler, et al.
Pageof 9